Varmus Resigns as NCI Director; Plans to Open Research Lab at Weill-Cornell, Assist NY Genome Center | GenomeWeb

NEW YORK (GenomeWeb) – Harold Varmus resigned as director of the National Cancer Institute today, effective at the end of March. He served as the institute's director for almost five years.

In a personal letter to the NCI community, he said that he will miss his job at the institute but looks forward to new opportunities in "the city, New York, that I continue to call home."

Starting in April, Varmus plans to establish a "modestly sized" research laboratory at the Meyer Cancer Center at Weill-Cornell Medical College and to serve as a senior advisor to its dean.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.

Mar
23
Sponsored by
Personal Genome Diagnostics

This webinar will discuss genomic methods to elucidate the molecular mechanisms underlying acquired resistance to immuno-oncology (IO) therapies.

Mar
28
Sponsored by
Illumina

This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment.